Published in J Hypertens on December 01, 1999
Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol (2007) 1.13
Blood pressure control in pediatric hemodialysis: the Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol (2006) 0.89
Design of the Blood Pressure Goals in Dialysis pilot study. Am J Med Sci (2014) 0.81
Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrol (2010) 0.77
Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study. PLoS One (2014) 0.75
Dialysis: prognostic value of blood pressure in patients on hemodialysis. Nat Rev Nephrol (2010) 0.75
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet (2002) 2.92
Low triiodothyronine and survival in end-stage renal disease. Kidney Int (2006) 1.88
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol (2001) 1.83
Reproducibility of the response to short-term low salt intake in essential hypertension. J Hypertens (1996) 1.76
Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol (2001) 1.54
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol (2001) 1.46
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc (2001) 1.29
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci (2001) 1.20
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant (2001) 1.12
Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int (1998) 1.07
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens (2000) 1.01
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med (2003) 0.99
Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int (2001) 0.99
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (2001) 0.98
Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med (2007) 0.97
AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant (2000) 0.97
Sleep apnea in renal patients. J Am Soc Nephrol (2001) 0.92
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med (2010) 0.88
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest (2003) 0.88
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant (2001) 0.88
Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med (2007) 0.88
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension. Am J Hypertens (2001) 0.87
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease. Kidney Int (2006) 0.86
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis (2011) 0.86
Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol (1986) 0.86
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension. J Nephrol (2000) 0.86
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. Arch Neurol (2001) 0.85
Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int (2007) 0.84
Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens (2001) 0.84
Sleep disordered breathing in renal transplant patients. Am J Transplant (2009) 0.83
Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease. Nephrol Dial Transplant (1995) 0.82
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis (2000) 0.81
Conceptual basis and methodology of the SOPHIA study. Pharmacogenomics (2007) 0.80
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol (1999) 0.80
Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J Nephrol (2005) 0.80
Plasma met-enkephalin and leu-enkephalin in chronic renal failure. Nephrol Dial Transplant (1987) 0.79
The reflex control of vasopressin in haemodialysis patients. Nephrol Dial Transplant (1991) 0.79
Management of hypertension in chronic kidney disease: the Italian multicentric study. J Nephrol (2005) 0.79
Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney Int (2007) 0.79
Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens (2000) 0.78
Body composition and bone mineral density in competitive athletes in different sports. Int J Tissue React (1996) 0.78
Presenilin 2 mutation does not influence expression and concentration of APP forms in human platelets. Mol Med (2000) 0.78
The role of endogenous opioids in the baroreflex dysfunction of dialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc (1985) 0.78
Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients. J Nephrol (2001) 0.78
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). Nutr Metab Cardiovasc Dis (2011) 0.77
Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. Clin Nephrol (1989) 0.77
[Biomarkers of prostate cancer. A review]. Minerva Urol Nefrol (2010) 0.77
The effects of muscle-building exercise on forearm bone mineral content and osteoblast activity in drug-free and anabolic steroids self-administering young men. Bone Miner (1991) 0.77
Does adipose tissue have a key role in inflammation in CKD? J Intern Med (2011) 0.77
Randomly allocated crossover study of various levels of sodium intake in patients with mild hypertension. J Hypertens Suppl (1993) 0.77
Prediction and consistency of blood pressure salt-sensitivity as assessed by a rapid volume expansion and contraction protocol. Salt-Sensitivity Study Group of the Italian Society of Hypertension. J Nephrol (2000) 0.77
The salt epidemic: old and new concerns. Nutr Metab Cardiovasc Dis (2000) 0.77
Assessment of the salt-arterial pressure relationship in mild hypertensive subjects by 24-hour ambulatory monitoring. Clin Sci (Lond) (1994) 0.76